On a full-year basis, revenue from operations for FY26 grew 18.9 percent year-on-year to Rs 827.87 crore compared to Rs 696.48 crore in FY25
Hikal’s Q4 profit remained sharply lower year-on-year, falling 71% from Rs. 50.2 crore in Q4 FY25 as the company absorbed regulatory pressures and strategic accounting adjustments
The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives
The new facility marks Align’s first manufacturing presence in India and its fourth globally
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
With over three decades of extensive industry experience, Ramesh Juneja brings a strong track record of building and scaling large businesses
Revenue from operations climbed 13% to Rs. 886.87 crore
The acquisition marks Anupam Rasayan’s strategic entry into the pharmaceutical formulations segment
Expands Davaindia network to 2,579 stores
Surya to lead medical governance, patient safety, clinical excellence, and quality assurance initiatives across the organization’s pan-India network.
Subscribe To Our Newsletter & Stay Updated
